Unlocking Growth in Targeted Oncology Therapy
Established Pharmaceutical Company
4→6
Active markets
+4pp
Prescription share
10-12%
YoY growth
An established pharmaceutical company had hit a growth ceiling at 6–7% YoY across 4 markets in its targeted oncology franchise.
Cap7tara identified 3 expansion markets, designed differentiated patient access programs, and activated 50–100 oncologists per market.
The engagement delivered +4pp prescription share gain in two months, expanding the active market footprint from 4 to 6 markets.
Patient access programs were designed with clinical rigor and tailored to local healthcare infrastructure, enabling rapid oncologist adoption and patient enrollment.